Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area.
Denis HorganYosr HamdiJonathan A LalTeresia NyawiraSalomé MeyerDominique KondjiNgiambudulu M FranciscoRoselle De GuzmanAnupriya PaulBranka BernardKrishna Reddy NallamallaWoong-Yang ParkVijay TripathiRavikant TripathiAmber JohnsMohan P SinghMaude E PhippsFrance DubeHadi Mohamad Abu RasheedMarta KozaricJoseph A PintoStephen Doral StefaniMaria Eugenia Aponte RuedaRicardo Fujita AlarconHugo A Barrera-SaldanaPublished in: Healthcare (Basel, Switzerland) (2023)
Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance: next-generation sequencing (NGS). This refined testing provides unprecedentedly precise diagnoses and permits the use of focused and highly personalized treatments. However, across regions globally, many cancer patients will continue to be denied the benefits of NGS as long as some of the yawning gaps in its implementation remain unattended. The challenges at the regional and national levels are linked because putting the solutions into effect is highly dependent on cooperation between regional- and national-level cooperation, which could be hindered by shortfalls in interpretation or understanding. The aim of the paper was to define and explore the necessary conditions for NGS and make recommendations for effective implementation based on extensive exchanges with policy makers and stakeholders. As a result, the European Alliance for Personalised Medicine (EAPM) developed a maturity framework structured around demand-side and supply-side issues to enable interested stakeholders in different countries to self-evaluate according to a common matrix. A questionnaire was designed to identify the current status of NGS implementation, and it was submitted to different experts in different institutions globally. This revealed significant variability in the different aspects of NGS uptake. Within different regions globally, to ensure those conditions are right, this can be improved by linking efforts made at the national level, where patients have needs and where care is delivered, and at the global level, where major policy initiatives in the health field are underway or in preparation, many of which offer direct or indirect pathways for building those conditions. In addition, in a period when consensus is still incomplete and catching up is needed at a political level to ensure rational allocation of resources-even within individual countries-to enable the best ways to make the necessary provisions for NGS, a key recommendation is to examine where closer links between national and regional actions could complement, support, and mutually reinforce efforts to improve the situation for patients.
Keyphrases
- quality improvement
- healthcare
- end stage renal disease
- ejection fraction
- public health
- primary care
- chronic kidney disease
- newly diagnosed
- mental health
- palliative care
- prognostic factors
- squamous cell carcinoma
- current status
- gene expression
- papillary thyroid
- mass spectrometry
- young adults
- dna methylation
- patient reported
- pain management
- climate change
- patient reported outcomes
- smoking cessation
- lymph node metastasis